SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP

Company

ADMA BIOLOGICS, INC.

Filed

June 16, 2017

Accession Number

0001387131-17-003298

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →